✦ LIBER ✦

Clinical safety of tazarotene in the treatment of plaque psoriasis

✍ Scribed by Ronald Marks

Book ID: 117396060
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 732 KB
Volume: 37
Category: Article
ISSN: 1097-6787
DOI: 10.1016/s0190-9622(97)80397-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of oral tazarotene in moderate to

Safety of oral tazarotene in moderate to severe plaque psoriasis

✍ Patricia S. Walker; Alice Gottlieb; Lyn Guenther; Alan Menter 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Duration of clinical improvement with or

Duration of clinical improvement with oral tazarotene in plaque psoriasis

✍ John Y.M. Koo; Nicholas Lowe; John Sefton; Patricia S. Walker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Tazarotene 0.1% gel plus corticosteroid

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

✍ Mark G. Lebwohl; Debra L. Breneman; Bernard S. Goffe; Jay R. Grossman; Mark R. L 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 94 KB

FC043 Tazarotene 0.1% gel plus corticost

FC043 Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

✍ J. Sefton; D.A. Lew-Kaya; M. Mierzwa; A. Vasilopoulos; J.C. Lue; J.R. Gibson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

An open-label extension study evaluating

An open-label extension study evaluating the efficacy and safety of oral tazarotene in plaque psoriasis

✍ Kim A Papp; Frederick Beddingfield; Susan Manrow; Patricia S. Walker 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The role of tazarotene in the treatment

The role of tazarotene in the treatment of psoriasis

✍ MARKS 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

The recent availability of tazarotene, the first receptor-selective retinoid, provides a much-needed addition to the therapeutic armamentarium for mild-to-moderate plaque psoriasis. Tazarotene gel offers a welcome combination of good efficacy and cosmetic acceptability, with minimal risk of systemic